Loading organizations...
Zabara Foundation advances transformative medical technology, focusing on neuromodulation to empower the body's intrinsic ability to combat disease. The organization supports the development of innovative therapies, particularly those involving vagus nerve stimulation (VNS), by exploring the nervous system as an integrated and autoregulated unit. This approach seeks to restore autoregulation within the human body through engineered devices.
The foundation continues the pioneering work of Dr. Jacob Zabara, a neuroscientist who originated modern vagus nerve stimulation in 1971. Dr. Zabara's insight challenged conventional understanding, proposing that the vagus nerve also transmits signals to the brain. This led to his invention of a VNS device and the subsequent establishment of Cyberonics, Inc. in 1987, built on his foundational research.
The medical technologies supported by the foundation serve individuals suffering from various chronic conditions, including epilepsy and depression, with potential applications extending to Parkinson’s disease, Alzheimer’s, and migraines. The long-term vision is to improve countless lives by expanding the utility of neuromodulation, solidifying the enduring impact of Dr. Zabara’s legacy in the field.
Key people at Zabara Foundation.
Zabara Foundation was founded by Jacob Zabara (Founder).
Key people at Zabara Foundation.
Zabara Foundation was founded by Jacob Zabara (Founder).
Zabara Foundation has 1 tracked investment across 1 company. The latest tracked deal is $8.5M Pre-Series A in Ampa in October 2025.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 22, 2025 | Ampa | $8.5M Pre-Series A | John Propst, PhD, MBA | Morningside Ventures, Satori Neuro |